Emerging Infectious Disease ISSN: 1080-6059

Evaluating Detection of an Inhalational Anthrax Outbreak

David L. Buckeridge*

, Douglas K. Owens†‡, Paul Switzer‡, John Frank§, and Mark A. Musen‡

Author affiliations: *McGill University, Montreal, Quebec, Canada; †Veterans Affairs Palo Alto Health Care System, Palo Alto, California, USA; ‡Stanford University, Stanford, California, USA; §University of Toronto, Toronto, Ontario, Canada

Main Article

Figure 2

Proportion of inhalational anthrax outbreaks detected by syndromic surveillance before clinical case finding (A) and mean detection benefit of syndromic surveillance compared with clinical case finding as a function of specificity (and false-alarm rate) (B) for 3 release scenarios. CI, confidence interval.

Figure 2. Proportion of inhalational anthrax outbreaks detected by syndromic surveillance before clinical case finding (A) and mean detection benefit of syndromic surveillance compared with clinical case finding as a function of specificity (and false-alarm rate) (B) for 3 release scenarios. CI, confidence interval.

Main Article

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.